For the ordinary workplace drug test, the short answer is no: kratom does not show up on a standard SAMHSA 5-panel or a typical 10-panel test. Those panels screen for a fixed list of substances — opioids, THC, cocaine, amphetamines, PCP, and a handful of others — and kratom's active compounds are not on that list. A routine screen is not looking for them and will not find them.
The longer answer has two important edges. First, a specialized test that specifically targets kratom does exist, and some employers, military branches, and probation programs use it. Second, the widely repeated claim that kratom "makes you fail for opioids" is mostly a myth — one worth getting exactly right, because the chemistry is clearer than the internet rumor suggests. This page covers both.
Safety & legal note. Kratom is not approved by the FDA for any use, and nothing here is medical advice or a recommendation to take any amount. Kratom is banned in some US states — check your local law. This article is educational, not legal advice.
What a standard panel actually screens for
A drug test does not check for "everything." It checks for a specific, pre-defined set of compounds, and it finds only what it is built to look for.
The federal reference point is the SAMHSA 5-panel, the screen used across most regulated and safety-sensitive workplaces:
| Standard 5-panel screens for | Kratom's alkaloids |
|---|---|
| THC (marijuana) | Not screened |
| Cocaine metabolites | Not screened |
| Opiates / opioids | Not screened |
| Amphetamines | Not screened |
| PCP | Not screened |
The 10-panel widens the net — adding benzodiazepines, barbiturates, methadone, and a few others — but the additions are more prescription and sedative categories. Mitragynine and 7-hydroxymitragynine, kratom's two main alkaloids, are not among the targets on either panel. So on the question people actually search — does kratom show up on a 10-panel test — the answer is the same as for the 5-panel: not as a standard target.
The reason is simple. An immunoassay screen uses antibodies calibrated to specific molecules. If a compound is not one the antibodies are raised against, the test has no way to register it. Kratom's alkaloids fall outside every target group on a standard panel.
The false-positive question, answered precisely
This is the part that gets repeated wrong, so it is worth being exact.
Mitragynine is chemically distinct from morphine, codeine, and the other opiates a drug screen's opioid antibodies are built to detect. Because of that structural difference, kratom does not normally cross-react on a standard opioid immunoassay — it does not typically cause a false positive for opioids. The common claim that taking kratom will light up the opiate line on a workplace test is, as a general rule, not supported.
The honest caveat: there are scattered case reports of kratom use coinciding with a false positive for an opioid such as methadone on an initial screen. These are the exception, not the pattern, and they matter less than they sound — because any non-negative screen is sent for confirmatory testing (typically GC-MS or LC-MS/MS), which identifies the exact molecule present. Confirmation distinguishes mitragynine from an actual opioid, so a rare screening artifact does not survive the second step.
So the accurate framing is narrow: a standard test is not looking for kratom, and kratom does not reliably trip the opioid marker it is looking for. The myth overstates a rare edge case into a rule.
The test that does catch it
Kratom's absence from standard panels is not because it is undetectable. It is because the standard panels are not built to look. A test built to look finds it easily.
A mitragynine-specific test — sometimes called a "kratom panel" — screens directly for kratom's alkaloids rather than the usual drug categories. It is not part of routine employment screening and is not what most people encounter, but it is a real, commercially available assay, and it is used in specific settings:
- Some employers in safety-sensitive roles who choose to add it
- Certain military screening programs
- Some probation, parole, and court-ordered testing regimes
If a program specifically wants to detect kratom, this is the tool, and a standard panel's blind spot does not apply to it. Whether a given test includes a kratom panel is a question only the testing entity can answer — it is not something you can infer from the words "drug test" alone.
Detection windows — reported ranges, not clinical precision
If a mitragynine-specific test is in use, how long the alkaloids remain detectable depends on the sample type, dose, frequency of use, metabolism, hydration, and body composition. The figures below are reported and estimated ranges commonly cited from limited pharmacokinetic data — treat them as rough orientation, not a guarantee for any individual.
| Sample | Reported detection window |
|---|---|
| Urine | Roughly a few days; longer with heavy, frequent use |
| Blood | Shortest window; typically about a day |
| Saliva | Short, comparable to blood |
| Hair | Longest; potentially weeks to months, though hair testing for kratom is uncommon |
Mitragynine has a relatively long elimination half-life compared with many substances, which is part of why urine windows are quoted in days rather than hours — and why heavy daily use pushes the upper end out further. But the underlying data set is small, so anyone quoting an exact number to the hour is claiming more precision than the evidence supports.
What this means in practice
Put together, the practical picture is straightforward:
- A routine 5- or 10-panel workplace test does not target kratom and does not detect it as a standard result.
- Kratom does not normally cause a false positive for opioids, and confirmatory testing resolves the rare exceptions.
- A kratom-specific panel exists and will detect it — but only where a program has chosen to include it, which is not the default.
If you are subject to a testing program and want certainty about what it covers, the only reliable source is the program itself, not a general rule. And none of the above is a statement about whether kratom is appropriate for you — that is a separate question we treat separately in is kratom safe.
Where to buy
If you are buying kratom, the thing that separates products is not the strain name — it is whether the vendor publishes current, per-batch third-party testing so you know what is actually in the bag. All three vendors we track do.
Kraken Kratom is our #1 pick: AKA-GMP qualified — the strongest trust signal in this market — and it publishes per-batch third-party lab testing with named analytical methods. Our code getketum takes 15% off at Kraken, and it is the only coupon on the site, so it is the one to use.
Two more we rank and trust:
- Kats Botanicals — per-batch testing with a batch-number lookup, broad powder and capsule menu.
- Kona Kratom — third-party tested value brand with a money-back guarantee and the cheapest bulk pricing we found.
For the full ranked comparison with testing and reputation scores, see best kratom vendors. New to the plant entirely? Start with what is kratom, and check whether it is legal where you are in our state overview.
The bottom line
- Standard 5-panel and 10-panel tests do not screen for kratom — its alkaloids are not among the targets, so it does not show up as a routine result.
- Kratom does not normally cause a false positive for opioids. Mitragynine is chemically distinct from opiates, and confirmatory testing clears the rare exceptions.
- A mitragynine-specific "kratom panel" exists and is used by some employers, the military, and probation programs — a standard panel's blind spot does not apply to it.
- Detection windows are estimates, not precise facts — urine is commonly cited in days, hair potentially longer, from a small data set.
- Only the testing program can tell you what its test covers. Treat everything here as general orientation, and remember kratom remains unapproved for any use.